Excess bone marrow B-cells in patients with multiple myeloma achieving complete remission following autologous stem cell transplantation is a biomarker for improved survival

British Journal of Haematology

Volumn 155, Issue 4, 2011, Pages 509-511

  Byrne, Elizabeth ^a   Naresh, Kikkeri N ^a   Giles, Chrissy ^a   Rahemtulla, Amin ^a  

^a IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

Bone marrow pathology; Myeloma; Transplantation

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; SYNDECAN 1;

ADULT; AGED; AUTOLOGOUS STEM CELL TRANSPLANTATION; B LYMPHOCYTE; BONE MARROW CELL; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOPHENOTYPING; LETTER; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROGNOSIS; REMISSION; TREATMENT OUTCOME;

ADULT; AGED; B-LYMPHOCYTES; BONE MARROW CELLS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIPLE MYELOMA; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 80054992118     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08700.x     Document Type: Letter

References (9)

1. Bladé, J., Samson, D., Reece, D., Apperley, J., Björkstrand, B., Gahrton, G., Gertz, M., Giralt, S., Jagannath, S. & Vesole, D. (1998) Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant. British Journal of Haematology, 102, 1115-1123.
2. Hall, S.L., Tate, J., Gill, D. & Mollee, P. (2009) Significance of abnormal protein bands in patients with multiple myeloma following autologous stem cell transplantation. The Clinical Biochemist. Reviews, 30, 113-118.
3. Hovenga, S., de Wolf, J.T., Guikema, J.E., Klip, H., Smit, J.W., Smit Sibinga, C.T., Bos, N.A. & Vellenga, E. (2000) Autologous stem cell transplantation in multiple myeloma after VAD and EDAP courses: a high incidence of oligoclonal serum Igs post transplantation. Bone Marrow Transplantation, 25, 723-728.
4. Kim, H., Sohn, H.J., Kim, S., Lee, J.S., Kim, W.K. & Suh, C. (2006) Early lymphocyte recovery predicts longer survival after autologous peripheral blood stem cell transplantation in multiple myeloma. Bone Marrow Transplantation, 37, 1037-1042.
5. Larrea, C.F., Trovar, N., Cibeira, M.T., Arostegui, J.I., Rosinol, L., Elena, M., Filella, X., Yague, J. & Blade, J. (2011) Emergence of oligoclonal bands in patients with multiple myeloma in complete remission after induction chemotherapy: association with the use of noval agents. Haematologica, 96, 171-173.
6. Rasmussen, T., Lodahl, M., Hancke, S. & Johnsen, H.E. (2004) In multiple myeloma clonotypic CD38-/CD19+/CD27+ memory B cells recirculate through bone marrow, peripheral blood and lymph nodes. Leukaemia and Lymphoma, 45, 1413-1417.
7. Szczepek, A.J., Seeberger, K., Wizniak, J., Mant, M.J., Belch, A.R. & Pilarski, L.M. (1998) A high frequency of circulating B cells share clonotypic Ig heavy-chain VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single-cell and in situ reverse transcriptase-polymerase chain reaction. Blood, 92, 2844-2855.
8. Terpos, E., Szydlo, R., Apperley, J.F., Hatjiharissi, E., Politou, M., Meletis, J., Viniou, N., Yataganas, X., Goldman, J. & Rahemtulla, A. (2003) Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index. Blood, 102, 1064-1069.
9. Zent, C.S., Wilson, C.S., Tricot, G., Jagannath, S., Siegel, D., Desikan, K.R., Munshi, N., Bracy, D., Barlogie, B. & Butch, A.W. (1998) Oligoclonal protein bands and Ig isotype switching in multiple myeloma treated with high-dose therapy and hematopoietic cell transplantation. Blood, 91, 3518-3523.